{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-17T08:03:25.371761+00:00","company":{"ticker":"ICUI","cik":883984,"company_name":"ICU MEDICAL INC/DE"},"pagination":{"limit":100,"returned":31,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"shareholder_vote","fact_key":"2cb672608b26cb587d963986641c52c99af4004b","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"failed","proposal_text":"Approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right.","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,979,477","subject":null,"votes_abstain":"10,661","votes_against":"13,124,012","votes_for":"9,009,640","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders rejected Approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 7. Approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Votes For Votes Against Votes Abstained Broker Non-Votes 9,009,640 13,124,012 10,661 1,979,477 The Company’s stockholders did not approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-2cb672608b26cb587d963986641c52c99af4004b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d61bfe2b8333aad79c201b179ba60258de38e1c0","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5.","proposal_type":"other","results":[{"broker_non_votes":"1,979,477","subject":null,"votes_abstain":"6,740","votes_against":"1,050,235","votes_for":"21,087,338","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 6. Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5. Votes For Votes Against Votes Abstained Broker Non-Votes 21,087,338 1,050,235 6,740 1,979,477 The Company’s stockholders approved an adjournment of the Annual Meeting, if necessary, to solicit additional proxies to approve Proposal 5.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-d61bfe2b8333aad79c201b179ba60258de38e1c0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"74ed6f5b15ee527c4c5430beb53ba6697d6b989b","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%.","proposal_type":"charter_amendment","results":[{"broker_non_votes":"1,979,477","subject":null,"votes_abstain":"1,268,627","votes_against":"131,314","votes_for":"20,744,372","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 5. Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%. Votes For Votes Against Votes Abstained Broker Non-Votes 20,744,372 131,314 1,268,627 1,979,477 The Company’s stockholders approved the Company's Amended and Restated Certificate of Incorporation to adopt a stockholder right to call special meetings at an ownership threshold of 25%.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-74ed6f5b15ee527c4c5430beb53ba6697d6b989b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"32cd26df905c91e1ffe924810f628b337f644c38","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions.","proposal_type":"charter_amendment","results":[{"broker_non_votes":"1,979,477","subject":null,"votes_abstain":"7,839","votes_against":"14,893","votes_for":"22,121,581","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 4. Approve an amendment to the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions. Votes For Votes Against Votes Abstained Broker Non-Votes 22,121,581 14,893 7,839 1,979,477 The Company’s stockholders approved the Company's Amended and Restated Certificate of Incorporation to adopt simple majority voting provisions.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-32cd26df905c91e1ffe924810f628b337f644c38","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3e4c60e1c287fc008e082126d45e944ef62987cc","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Approve, on an advisory basis, the Company’s named executive officer compensation.","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,979,477","subject":null,"votes_abstain":"12,690","votes_against":"920,098","votes_for":"21,211,525","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Approve, on an advisory basis, the Company’s named executive officer compensation. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 3. Approve, on an advisory basis, the Company’s named executive officer compensation. Votes For Votes Against Votes Abstained Broker Non-Votes 21,211,525 920,098 12,690 1,979,477 The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-3e4c60e1c287fc008e082126d45e944ef62987cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"3a25403479bac0f0da90c1a5457b26420ed09f29","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"5,849","votes_against":"255,744","votes_for":"23,862,197","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained Broker Non-Votes 23,862,197 255,744 5,849 0 The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-3a25403479bac0f0da90c1a5457b26420ed09f29","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"shareholder_vote","fact_key":"00fed92ee14e14c681a1cf395b7e64aeb35c8dee","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-13","outcome":"passed","proposal_text":"Election of directors","proposal_type":"director_election","results":[{"broker_non_votes":"1,979,477","subject":"Vivek Jain","votes_abstain":"0","votes_against":"0","votes_for":"21,830,140","votes_withheld":"314,173"},{"broker_non_votes":"1,979,477","subject":"David C. Greenberg","votes_abstain":"0","votes_against":"0","votes_for":"21,838,112","votes_withheld":"306,201"},{"broker_non_votes":"1,979,477","subject":"Elisha W. Finney","votes_abstain":"0","votes_against":"0","votes_for":"21,875,087","votes_withheld":"269,226"},{"broker_non_votes":"1,979,477","subject":"David F. Hoffmeister","votes_abstain":"0","votes_against":"0","votes_for":"21,951,116","votes_withheld":"193,197"},{"broker_non_votes":"1,979,477","subject":"Donald M. Abbey","votes_abstain":"0","votes_against":"0","votes_for":"21,880,077","votes_withheld":"264,236"},{"broker_non_votes":"1,979,477","subject":"Laurie Hernandez","votes_abstain":"0","votes_against":"0","votes_for":"21,881,172","votes_withheld":"263,141"},{"broker_non_votes":"1,979,477","subject":"Kolleen T. Kennedy","votes_abstain":"0","votes_against":"0","votes_for":"21,881,304","votes_withheld":"263,009"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Election of directors at the 2026-05-13 meeting.","evidence_excerpt":"Proposal 1. Election of directors. Name of Nominee Votes For Withheld Broker Non-Votes Vivek Jain 21,830,140 314,173 1,979,477 David C. Greenberg 21,838,112 306,201 1,979,477 Elisha W. Finney 21,875,087 269,226 1,979,477 David F. Hoffmeister 21,951,116 193,197 1,979,477 Donald M. Abbey 21,880,077 264,236 1,979,477 Laurie Hernandez 21,881,172 263,141 1,979,477 Kolleen T. Kennedy 21,881,304 263,009 1,979,477 The Company’s stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is duly elected and qualified.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-00fed92ee14e14c681a1cf395b7e64aeb35c8dee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"governance_change","fact_key":"867e37fef69aec55de769aee452f18f0766385e8","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2026-05-15","item_codes_triggered":["5.03"],"summary_text":"Amended and restated bylaws to adopt procedural and informational requirements implementing the special meeting amendment."},"claim":"ICU MEDICAL INC/DE: Amended and restated bylaws to adopt procedural and informational requirements implementing the special meeting amendment (effective 2026-05-15).","evidence_excerpt":"The Board also approved, contingent on stockholder approval and effectiveness of the Charter Amendments, an amendment and restatement of the Company’s Bylaws (as amended and restated, the “Amended and Restated Bylaws”), which became effective upon the effectiveness of the Charter Amendments, to adopt certain changes to implement the Charter Amendments.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-867e37fef69aec55de769aee452f18f0766385e8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"governance_change","fact_key":"94145e3eda4206f76d4913592257ec7b2ba9413a","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-18T16:35:44+00:00","payload":{"change_type":"charter_amendment","effective_date":"2026-05-15","item_codes_triggered":["5.03"],"summary_text":"Amended and restated certificate of incorporation to adopt simple majority voting provisions, stockholder right to call special meetings at 25% threshold, and remove other obsolete provisions."},"claim":"ICU MEDICAL INC/DE: Amended and restated certificate of incorporation to adopt simple majority voting provisions, stockholder right to call special meetings at 25% threshold, and remove other obsolete provisions (effective 2026-05-15).","evidence_excerpt":"At the Annual Meeting, the Company’s stockholders approved amendments to the Company’s Amended and Restated Certificate of Incorporation to: (i) eliminate certain provisions that require a supermajority vote of stockholders and provide for a simple majority vote (the “Majority Voting Amendment”); (ii) permit stockholders owning no less than 25% of the combined voting power of all outstanding voting securities of the Company the right to call a special meeting of stockholders (“Special Meeting Amendment”); and (iii) remove such other provisions no longer applicable (collectively, the “Charter Amendments”). The Charter Amendments became effective upon filing an Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 15, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-26-000031","anchor_url":"https://secwatch.observer/filing/0000883984-26-000031#claim-94145e3eda4206f76d4913592257ec7b2ba9413a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000031/0000883984-26-000031-index.htm"},{"fact_type":"earnings_release","fact_key":"456d4334ece7bf4efc19d62c813ad35f184f11a4","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2026-05-07T23:59:59+00:00","payload":{"eps_text":"$1.20 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$30.1 million","period_text":"first quarter of 2026","report_date":"2026-05-07","result_type":"reported_results","revenue_text":"$530.2 million"},"claim":"ICU MEDICAL INC/DE reported first quarter of 2026 results: revenue $530.2 million, net income $30.1 million, EPS $1.20 per diluted share.","evidence_excerpt":"First quarter 2026 GAAP revenue was $530.2 million, as compared to $604.7 million in the same period in the prior year. GAAP gross profit for the first quarter of 2026 was $206.2 million, as compared to $210.1 million in the same period in the prior year. GAAP gross margin for the first quarter of 2026 was 39%, as compared to 35% in the same period in the prior year. GAAP net income for the first quarter of 2026 was $30.1 million, or $1.20 per diluted share","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-26-000028","anchor_url":"https://secwatch.observer/filing/0000883984-26-000028#claim-456d4334ece7bf4efc19d62c813ad35f184f11a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/0000883984-26-000028-index.htm"},{"fact_type":"executive_change","fact_key":"c1b8fa9a92","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-10-02T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-30","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Daniel Woolson was appointed as President at ICU MEDICAL INC/DE.","evidence_excerpt":"On September 30, 2024, the Board of Directors of ICU Medical, Inc. (the “Company”) appointed Mr. Daniel Woolson, 48, as President of the Company, effective immediately.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-24-000032","anchor_url":"https://secwatch.observer/filing/0000883984-24-000032#claim-c1b8fa9a92","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000032/0000883984-24-000032-index.htm"},{"fact_type":"shareholder_vote","fact_key":"ceace878356555685341204ca62af4217cd0118d","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-05-16T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-15","outcome":"passed","proposal_text":"Approve the advisory vote on the Company’s named executive officer compensation","proposal_type":"say_on_pay","votes_abstain_text":"15,138","votes_against_text":"824,221","votes_for_text":"20,673,543"},"claim":"ICU MEDICAL INC/DE shareholders approved Approve the advisory vote on the Company’s named executive officer compensation at the 2024-05-15 meeting.","evidence_excerpt":"The Company’s stockholders approved, on an advisory basis, the Company’s named executive officer compensation.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-24-000018","anchor_url":"https://secwatch.observer/filing/0000883984-24-000018#claim-ceace878356555685341204ca62af4217cd0118d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm"},{"fact_type":"shareholder_vote","fact_key":"a63ac92ef9b77a7cb459fe12b08c14dbbe816063","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-05-16T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-15","outcome":"passed","proposal_text":"Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024","proposal_type":"auditor_ratification","votes_abstain_text":"8,691","votes_against_text":"222,466","votes_for_text":"22,484,283"},"claim":"ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-15 meeting.","evidence_excerpt":"The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-24-000018","anchor_url":"https://secwatch.observer/filing/0000883984-24-000018#claim-a63ac92ef9b77a7cb459fe12b08c14dbbe816063","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm"},{"fact_type":"shareholder_vote","fact_key":"7cdf88d57904472ab6e38a96027464f9d1554c74","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-05-16T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-15","outcome":"passed","proposal_text":"Election of directors","proposal_type":"director_election","votes_abstain_text":null,"votes_against_text":null,"votes_for_text":null},"claim":"ICU MEDICAL INC/DE shareholders approved Election of directors at the 2024-05-15 meeting.","evidence_excerpt":"The Company’s stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is elected and qualified.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-24-000018","anchor_url":"https://secwatch.observer/filing/0000883984-24-000018#claim-7cdf88d57904472ab6e38a96027464f9d1554c74","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000018/0000883984-24-000018-index.htm"},{"fact_type":"executive_change","fact_key":"c8884da828","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-02-29T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"retirement","effective_date":"2024-02-28","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"William Seeger resigned as Director at ICU MEDICAL INC/DE.","evidence_excerpt":"On February 28, 2024, Mr. William Seeger notified the board of directors (the “Board”) of ICU Medical, Inc. (the “Company”) that he will retire from the board of directors of Smiths Group plc (“Smiths”) on May 31, 2024 and, in anticipation of his retirement, tendered his resignation from the Company Board and a member of the Audit and Compliance Committee of the Company Board as Smiths’ nominated director, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-24-000007","anchor_url":"https://secwatch.observer/filing/0000883984-24-000007#claim-c8884da828","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000007/0000883984-24-000007-index.htm"},{"fact_type":"earnings_release","fact_key":"9ddf449544d0335d304092bda7253c84257ffdf3","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-02-27T23:59:59+00:00","payload":{"eps_text":"$(0.71) per diluted share","guidance_signal":"unknown","item_codes_triggered":["2.02"],"net_income_text":"$(17.1) million","period_text":"fourth quarter of 2023","report_date":"2024-02-27","result_type":"reported_results","revenue_text":"$587.9 million"},"claim":"ICU MEDICAL INC/DE reported fourth quarter of 2023 results: revenue $587.9 million, net income $(17.1) million, EPS $(0.71) per diluted share.","evidence_excerpt":"and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the same","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-24-000004","anchor_url":"https://secwatch.observer/filing/0000883984-24-000004#claim-9ddf449544d0335d304092bda7253c84257ffdf3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/0000883984-24-000004-index.htm"},{"fact_type":"earnings_release","fact_key":"dfdef1abe894743159cd64edac580daabb7959c8","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-11-06T23:59:59+00:00","payload":{"eps_text":"$0.30 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$7.2 million","period_text":"third quarter of 2023","report_date":"2023-11-06","result_type":"reported_results","revenue_text":"$553.3 million"},"claim":"ICU MEDICAL INC/DE reported third quarter of 2023 results: revenue $553.3 million, net income $7.2 million, EPS $0.30 per diluted share.","evidence_excerpt":"Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-23-000037","anchor_url":"https://secwatch.observer/filing/0000883984-23-000037#claim-dfdef1abe894743159cd64edac580daabb7959c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000037/0000883984-23-000037-index.htm"},{"fact_type":"governance_change","fact_key":"709765b0b65f0941d7fbb4b607a49e89753ead15","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-11-03T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2023-10-30","item_codes_triggered":["5.03"],"summary_text":"Amended bylaws to adopt universal proxy rules, enhance stockholder nomination procedures, require non-white proxy cards, and adopt exclusive forum provisions for Delaware and federal securities claims."},"claim":"ICU MEDICAL INC/DE: Amended bylaws to adopt universal proxy rules, enhance stockholder nomination procedures, require non-white proxy cards, and adopt exclusive forum provisions for Delaware and federal securities claims (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023, the Board of Directors (“Board”) of ICU Medical, Inc. (the “Company”) adopted amendments to the Company’s amended and restated bylaws (as amended, the “Amended and Restated Bylaws”), which became effective the same day.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-23-000034","anchor_url":"https://secwatch.observer/filing/0000883984-23-000034#claim-709765b0b65f0941d7fbb4b607a49e89753ead15","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000034/0000883984-23-000034-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e16c5b76edf9dd7a41d4791fa8d33839e6d94290","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-22T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Advisory vote to determine the frequency of future advisory votes on the Company's named executive officer compensation","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"1,022,878","subject":null,"votes_abstain":"16,553","votes_against":"0","votes_for":"22,475,185","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Advisory vote to determine the frequency of future advisory votes on the Company's named executive officer compensation.","evidence_excerpt":"Proposal 5. Advisory vote to determine the frequency of future advisory votes on the Company's named executive officer compensation. 1 Year 2 Years 3 Years Votes Abstained Broker Non-Votes 22,475,185 1,721 114,486 16,553 1,022,878","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-23-000024","anchor_url":"https://secwatch.observer/filing/0000883984-23-000024#claim-e16c5b76edf9dd7a41d4791fa8d33839e6d94290","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000024/0000883984-23-000024-index.htm"},{"fact_type":"shareholder_vote","fact_key":"65a4af844b35dc663cb9bc2fc90eace1bf6a1810","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-22T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Approve the advisory vote on the Company's named executive officer compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"1,022,878","subject":null,"votes_abstain":"14,168","votes_against":"772,716","votes_for":"21,821,061","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Approve the advisory vote on the Company's named executive officer compensation.","evidence_excerpt":"Proposal 4.  Approve the advisory vote on the Company’s named executive officer compensation. Votes For Votes Against Votes Abstained Broker Non-Votes 21,821,061 772,716 14,168 1,022,878","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-23-000024","anchor_url":"https://secwatch.observer/filing/0000883984-23-000024#claim-65a4af844b35dc663cb9bc2fc90eace1bf6a1810","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000024/0000883984-23-000024-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f1e0e4f9150ed15d80f1b2170c1ea875a68600d5","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-22T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-12-31","outcome":"passed","proposal_text":"Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"0","subject":null,"votes_abstain":"6,636","votes_against":"1,082,300","votes_for":"22,541,887","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-12-31 meeting.","evidence_excerpt":"Proposal 3. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes For Votes Against Votes Abstained Broker Non-Votes 22,541,887 1,082,300 6,636 0","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-23-000024","anchor_url":"https://secwatch.observer/filing/0000883984-23-000024#claim-f1e0e4f9150ed15d80f1b2170c1ea875a68600d5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000024/0000883984-23-000024-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9a679d278b3eb97a6520f170e278605b7bfe7933","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-22T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"To approve an Amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan","proposal_type":"equity_plan","results":[{"broker_non_votes":"1,022,878","subject":null,"votes_abstain":"9,099","votes_against":"1,003,038","votes_for":"21,595,808","votes_withheld":"0"}]},"claim":"ICU MEDICAL INC/DE shareholders approved To approve an Amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan.","evidence_excerpt":"Proposal 2. To approve an Amendment to the Amended and Restated ICU Medical, Inc. 2011 Stock Incentive Plan. Votes For Votes Against Votes Abstained Broker Non-Votes 21,595,808 1,003,038 9,099 1,022,878","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-23-000024","anchor_url":"https://secwatch.observer/filing/0000883984-23-000024#claim-9a679d278b3eb97a6520f170e278605b7bfe7933","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000024/0000883984-23-000024-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e04842fc2c0e6a68035c79bae07fb6c13ed67a6e","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-22T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":null,"outcome":"passed","proposal_text":"Election of directors","proposal_type":"director_election","results":[{"broker_non_votes":"1,022,878","subject":"Vivek Jain","votes_abstain":"0","votes_against":"0","votes_for":"22,282,068","votes_withheld":"325,877"},{"broker_non_votes":"1,022,878","subject":"George A. Lopez, M.D.","votes_abstain":"0","votes_against":"0","votes_for":"22,429,987","votes_withheld":"177,958"},{"broker_non_votes":"1,022,878","subject":"David C. Greenberg","votes_abstain":"0","votes_against":"0","votes_for":"22,369,956","votes_withheld":"237,989"},{"broker_non_votes":"1,022,878","subject":"Elisha W. Finney","votes_abstain":"0","votes_against":"0","votes_for":"20,375,053","votes_withheld":"2,232,892"},{"broker_non_votes":"1,022,878","subject":"David F. Hoffmeister","votes_abstain":"0","votes_against":"0","votes_for":"20,529,227","votes_withheld":"2,078,718"},{"broker_non_votes":"1,022,878","subject":"Donald M. Abbey","votes_abstain":"0","votes_against":"0","votes_for":"22,388,339","votes_withheld":"219,606"},{"broker_non_votes":"1,022,878","subject":"Laurie Hernandez","votes_abstain":"0","votes_against":"0","votes_for":"22,391,633","votes_withheld":"216,312"},{"broker_non_votes":"1,022,878","subject":"Kolleen T. Kennedy","votes_abstain":"0","votes_against":"0","votes_for":"22,429,621","votes_withheld":"178,324"},{"broker_non_votes":"1,022,878","subject":"William Seeger","votes_abstain":"0","votes_against":"0","votes_for":"22,429,386","votes_withheld":"178,559"}]},"claim":"ICU MEDICAL INC/DE shareholders approved Election of directors.","evidence_excerpt":"Proposal 1.  Election of directors. Name of Nominee Votes For Withheld Broker Non-Votes Vivek Jain 22,282,068 325,877 1,022,878 George A. Lopez, M.D. 22,429,987 177,958 1,022,878 David C. Greenberg 22,369,956 237,989 1,022,878 Elisha W. Finney 20,375,053 2,232,892 1,022,878 David F. Hoffmeister 20,529,227 2,078,718 1,022,878 Donald M. Abbey 22,388,339 219,606 1,022,878 Laurie Hernandez 22,391,633 216,312 1,022,878 Kolleen T. Kennedy 22,429,621 178,324 1,022,878 William Seeger 22,429,386 178,559 1,022,878","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000883984-23-000024","anchor_url":"https://secwatch.observer/filing/0000883984-23-000024#claim-e04842fc2c0e6a68035c79bae07fb6c13ed67a6e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000024/0000883984-23-000024-index.htm"},{"fact_type":"earnings_release","fact_key":"707698a1d4805f3fbcf6901c6c1368dab9be15b4","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-05-08T23:59:59+00:00","payload":{"eps_text":"$(0.41) per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$(9.8) million","period_text":"the quarter ended March 31, 2023","report_date":"2023-05-08","result_type":"reported_results","revenue_text":"$568.6 million"},"claim":"ICU MEDICAL INC/DE reported the quarter ended March 31, 2023 results: revenue $568.6 million, net income $(9.8) million, EPS $(0.41) per diluted share.","evidence_excerpt":"First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was $192.0 million, as compared to $168.8 million in the same period last year. GAAP gross margin for the first quarter of 2023 was 34%, as compared to 31% in the same period last year. GAAP net loss for the first quarter of 2023 was $(9.8) million, or $(0.41) per diluted share, as compared to GAAP net loss of $(38.1) million, or $(1.61) per diluted share, for the first quarter of 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-23-000020","anchor_url":"https://secwatch.observer/filing/0000883984-23-000020#claim-707698a1d4805f3fbcf6901c6c1368dab9be15b4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000020/0000883984-23-000020-index.htm"},{"fact_type":"earnings_release","fact_key":"e262b13f9589bdb20cf6c64d9eda3e81bd530a4d","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2023-02-27T23:59:59+00:00","payload":{"eps_text":"$(0.65) per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$(15.5) million","period_text":"the fourth quarter of 2022","report_date":"2023-02-27","result_type":"reported_results","revenue_text":"$578.0 million"},"claim":"ICU MEDICAL INC/DE reported the fourth quarter of 2022 results: revenue $578.0 million, net income $(15.5) million, EPS $(0.65) per diluted share.","evidence_excerpt":"Fourth quarter 2022 revenue was $578.0 million, compared to $340.5 million in the same period last year. GAAP gross profit for the fourth quarter of 2022 was $174.9 million, as compared to $127.5 million in the same period last year. GAAP gross margin for the fourth quarter of 2022 was 30%, as compared to 37% in the same period last year. GAAP net loss for the fourth quarter of 2022 was $(15.5) million, or $(0.65) per diluted share, as compared to GAAP net income of $19.9 million, or $0.91 per diluted share, for the fourth quarter of 2021.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000883984-23-000007","anchor_url":"https://secwatch.observer/filing/0000883984-23-000007#claim-e262b13f9589bdb20cf6c64d9eda3e81bd530a4d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/0000883984-23-000007-index.htm"},{"fact_type":"earnings_release","fact_key":"294d39a1d15e64e72e87be63ffd5bbc8b686e14c","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-11-07T23:59:59+00:00","payload":{"eps_text":"Adjusted diluted earnings per share for the third quarter of 2022 was $1.75","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"GAAP net loss for the third quarter of 2022 was $(13.2) million","period_text":"For the quarter ended September 30, 2022","report_date":"2022-11-07","result_type":"reported_results","revenue_text":"Third quarter 2022 revenue was $597.9 million"},"claim":"ICU MEDICAL INC/DE reported For the quarter ended September 30, 2022 results: revenue Third quarter 2022 revenue was $597.9 million, net income GAAP net loss for the third quarter of 2022 was $(13.2) million, EPS Adjusted diluted earnings per share for the third quarter of 2022 was $1.75. Guidance reaffirmed.","evidence_excerpt":"ICU Medical Announces Third Quarter 2022 Results The Company Reaffirms 2022 Fiscal Year Guidance","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-22-000044","anchor_url":"https://secwatch.observer/filing/0000883984-22-000044#claim-294d39a1d15e64e72e87be63ffd5bbc8b686e14c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm"},{"fact_type":"executive_change","fact_key":"e34d9b39d9","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-02-18T23:59:59+00:00","payload":{"action":"retire","action_category":"departure","departure_tone":"retirement","effective_date":"2022-03-18","interim":false,"role":"Chief Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Kevin McGrody departed as Chief Accounting Officer at ICU MEDICAL INC/DE.","evidence_excerpt":"On February 16, 2022, Kevin McGrody, age 63, informed ICU Medical, Inc. (the “Company”) of his intention to retire as Chief Accounting Officer of the Company effective March 18, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-22-000009","anchor_url":"https://secwatch.observer/filing/0000883984-22-000009#claim-e34d9b39d9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000009/0000883984-22-000009-index.htm"},{"fact_type":"executive_change","fact_key":"d01d4e7664","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-02-01T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-02-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"William Seeger was appointed as Director at ICU MEDICAL INC/DE.","evidence_excerpt":"appointed William Seeger to serve as a director of the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-22-000007","anchor_url":"https://secwatch.observer/filing/0000883984-22-000007#claim-d01d4e7664","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000007/0000883984-22-000007-index.htm"},{"fact_type":"executive_change","fact_key":"923f4da072","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-01-04T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2021-12-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Kolleen Kennedy was elected as Director at ICU MEDICAL INC/DE.","evidence_excerpt":"On December 31, 2021, the Board elected Ms. Kolleen Kennedy as a new director of the Company, effective December 31, 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-22-000002","anchor_url":"https://secwatch.observer/filing/0000883984-22-000002#claim-923f4da072","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000002/0000883984-22-000002-index.htm"},{"fact_type":"executive_change","fact_key":"7edd3101ee","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2022-01-04T23:59:59+00:00","payload":{"action":"resignation","action_category":"departure","departure_tone":"retirement","effective_date":"2021-12-31","interim":false,"role":"Director","role_category":"director","successor_name":"Kolleen Kennedy","successor_named":true},"claim":"Robert S. Swinney departed as Director at ICU MEDICAL INC/DE.","evidence_excerpt":"On December 31, 2021, Robert S. Swinney notified ICU Medical, Inc. (the “Company”) of his resignation, effective December 31, 2021 from the Company’s Board of Directors (the “Board”) in accordance with the Board’s retirement policy after 24 years of service.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-22-000002","anchor_url":"https://secwatch.observer/filing/0000883984-22-000002#claim-7edd3101ee","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398422000002/0000883984-22-000002-index.htm"},{"fact_type":"executive_change","fact_key":"9bf3a4dc74","cik":883984,"ticker":"ICUI","company_name":"ICU MEDICAL INC/DE","filed_at":"2021-07-07T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2021-07-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Laurie Hernandez was elected as Director at ICU MEDICAL INC/DE.","evidence_excerpt":"On July 1, 2021, the Board of Directors (the “Board”) of the Company elected Ms. Laurie Hernandez as the new director of the Company, effective July 1, 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000883984-21-000020","anchor_url":"https://secwatch.observer/filing/0000883984-21-000020#claim-9bf3a4dc74","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/883984/000088398421000020/0000883984-21-000020-index.htm"}]}